{"id":"W2979640471","doi":"10.1182/blood.v120.21.985.985","title":"Eculizumab (ECU) Safety and Efficacy in Atypical Hemolytic Uremic Syndrome (aHUS) Patients with Long Disease Duration and Chronic Kidney Disease (CKD): 2-Year Results","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Eculizumab; Atypical hemolytic uremic syndrome; Medicine; Thrombotic microangiopathy; Dialysis; Kidney disease; Internal medicine; Population; Renal function; Gastroenterology; End stage renal disease; Hemodialysis; Surgery; Complement system; Disease; Immunology; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001558743,0.0002414211,0.0002777108,0.000105705,0.0001470384,0.00002412487,0.0001159996,0.00008667874,0.0001154994],"category_scores_gemma":[0.0003701397,0.0002056696,0.00004132262,0.0001203735,0.0001733773,0.0002144341,0.000133792,0.0001551717,0.00007104225],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008709533,"about_ca_system_score_gemma":0.0001451248,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001480608,"about_ca_topic_score_gemma":0.00001795783,"domain_scores_codex":[0.998354,0.0002157982,0.0004574421,0.0004192452,0.00008506013,0.000468483],"domain_scores_gemma":[0.9989873,0.0001268777,0.0001445193,0.0003706591,0.00003626196,0.0003344099],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00619064,0.002023108,0.9902893,0.0002076793,0.0001481275,0.00004495337,0.0001491807,0.000003256673,0.0002830256,0.000156246,0.0002808687,0.0002236086],"study_design_scores_gemma":[0.02063676,0.0002239132,0.9775094,0.0003550828,0.0002969517,0.00002968727,0.00001839961,0.000004912391,0.0001030989,0.00001081287,0.0005492491,0.0002617092],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945238,0.003573983,0.000008454049,0.0001681869,0.0001486512,0.0008935086,0.00058221,0.00005648566,0.00004474544],"genre_scores_gemma":[0.9983361,0.00005143809,0.0000134612,0.00005872701,0.00003727421,0.00003935778,0.001364028,0.00002341114,0.00007618862],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01444612,"threshold_uncertainty_score":0.8386963,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006024240597087886,"score_gpt":0.2125440736484064,"score_spread":0.2065198330513185,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}